• Reframing Pyroptosis: Caspase-4 Assays in Translational Onco

  2026-07-24

  This thought-leadership article investigates the intersection between organelle-targeted cell death strategies and advanced colorimetric detection of inflammatory caspase activity. By bridging mechanistic insight from enzyme-instructed self-assembly (EISA) in cancer therapy with practical guidance on leveraging the Caspase-4 Colorimetric Assay Kit, we offer translational researchers a roadmap for dissecting cell fate with molecular precision and clinical relevance.

• Sodium Overload Disrupts Mitochondrial Metabolism in NECSO

  2026-07-24

  Qiao et al. reveal how sodium influx, mediated by TRPM4 activation, impairs mitochondrial energy metabolism and drives necrosis by sodium overload (NECSO). Their mechanistic insights clarify the link between sodium dysregulation, mitochondrial dysfunction, and cell death, with implications for studying cell injury and apoptosis in disease contexts.

• Organic Cation Transporter Response to Xenobiotics in Aedes

  2026-07-23

  Kennel and Rouhier's 2025 study reveals how Aedes aegypti mosquitoes physiologically respond to synthetic dyes and the role of putative organic cation transporters (OCTs/OCTNs) in xenobiotic clearance. Their findings identify the molecular structure of xenobiotics as a key determinant in excretion and mortality, informing future molecular strategies for vector control.

• SAG: Advancing Hedgehog Pathway Activation for Translational

  2026-07-23

  Explore how Smoothened Agonist (SAG) enables precise and reproducible Hedgehog pathway activation, transforming translational research from stem cell maintenance to neuroprotection and tumorigenesis. This thought-leadership article integrates mechanistic insight, protocol essentials, and emerging evidence—including recent antagonist discovery—to guide investigators in leveraging SAG’s unique capabilities with scientific rigor and translational foresight.

• BIIE 0246: Applied NeuroPeptide Y Y2 Receptor Antagonist Wor

  2026-07-22

  BIIE 0246 empowers researchers to dissect neuropeptide Y Y2 receptor function with nanomolar precision—enabling robust exploration of feeding, anxiety, and neuro-adipose-cardiac signaling. This guide translates advanced experimental models and recent breakthroughs into actionable protocols and troubleshooting strategies for maximizing BIIE 0246’s impact in neuroscience and cardiometabolic research.

• Advancing Glucose Uptake Assays for Cancer Resistance Resear

  2026-07-22

  This thought-leadership article explores how high-resolution glucose uptake assays, such as the 2-NBDG Glucose Uptake Assay Kit, are powering a new wave of translational research into metabolic reprogramming and drug resistance in hepatocellular carcinoma. Drawing on recent mechanistic discoveries around HNF4A-AS1-mediated metabolic adaptation, it outlines experimental strategies, competitive landscape insights, and actionable guidance for researchers aiming to bridge metabolic phenotyping with therapeutic innovation.

• Calnexin’s Role in CFTR Variant Rescue: Deep Mutational Insi

  2026-07-21

  Tedman et al. systematically map how the ER chaperone calnexin influences plasma membrane expression and drug responsiveness across 232 CFTR variants. Their findings reveal domain-dependent requirements for calnexin in both CFTR biogenesis and corrector efficacy, offering a blueprint for variant-specific cystic fibrosis therapy development.

• Multiplexed ACE2 Libraries Reveal SARS-CoV-2 Variant Adaptat

  2026-07-21

  This study introduces a high-throughput barcoded infection assay to systematically test how SARS-CoV-2 spike variants interact with diverse ACE2 receptor variants. The findings show that viral spike mutations can shift compatibility with both human and animal ACE2 orthologs, illuminating routes of cross-species transmission and viral adaptation.

• METTL14-m6A-lncRNA Axis Modulates Inflammation in Ulcerative

  2026-07-20

  This study uncovers how METTL14 regulates ulcerative colitis inflammation via m6A modification of lncRNA DHRS4-AS1, influencing the miR-206/A3AR pathway. The findings offer mechanistic insight into RNA modification in IBD and highlight new therapeutic targets for chronic colonic inflammation.

• AO/PI Staining Solution: Precision in Fluorescent Cell Viabi

  2026-07-20

  AO/PI Staining Solution elevates fluorescence-based cell counting by enabling reliable live/dead discrimination, outperforming traditional stains in both routine and challenging research contexts. Its robust dual-dye system is especially advantageous for mechanistic studies of inflammation, cytotoxicity, and apoptosis, bridging precise quantification with translational impact.

• LINC02613 Silencing Inhibits OSCC Metastasis via LCP1 Ubiqui

  2026-07-19

  This study identifies LINC02613 as a key long noncoding RNA promoting oral squamous cell carcinoma (OSCC) metastasis by interfering with LCP1 ubiquitination and degradation. Targeted delivery of siLINC02613 using pH-responsive nanoparticles suppressed OSCC progression, highlighting a promising therapeutic avenue for metastatic disease.

• Vitamin C (CAS 50-81-7): Reliable Solutions for Cell-Based A

  2026-07-18

  This article delivers practical, data-driven strategies for integrating Vitamin C (CAS 50-81-7) (SKU B2064) into cell viability, proliferation, and cytotoxicity workflows. By addressing real-world experimental challenges, it guides biomedical researchers and lab technicians in leveraging high-purity ascorbic acid for reproducibility and result consistency.

• Optimizing Assays with 3X (DYKDDDDK) Peptide: Data-Driven So

  2026-07-17

  This article guides biomedical researchers through common challenges in protein detection and purification, demonstrating how the 3X (DYKDDDDK) Peptide (SKU A6001) offers reliable, reproducible solutions. Scenario-driven Q&As address protocol optimization, antibody compatibility, and vendor selection, with practical insights and direct links to validated resources. Designed for scientists seeking robust, evidence-based workflows using the 3X FLAG peptide.

• TMRE Mitochondrial Membrane Potential Assay Kit: Precision,

  2026-07-17

  Explore the TMRE mitochondrial membrane potential assay kit as a powerful tool for decoding mitochondrial function and sodium-induced dysfunction. This in-depth article uniquely connects assay fundamentals to the latest mechanistic research, equipping scientists with advanced insight for apoptosis and metabolism studies.

• Improved In Vitro Assessment of Cancer Drug Responses

  2026-07-16

  Schwartz's dissertation redefines how drug efficacy is evaluated in vitro by distinguishing between proliferative arrest and cell death, rather than using a single viability metric. This nuanced framework enables more accurate characterization of anti-cancer agents, supporting reliable assay design and translational research.

11505 records 1/767 page Next 12345 下5页 Last page